| Course Title | Code | Language | Type | Semester | L+U Hour | Credits | ECTS |
|---|---|---|---|---|---|---|---|
| Pharmacology III | ECZ403 | Turkish | Compulsory | 7. Semester | 3 + 0 | 3.0 | 3.0 |
| Prerequisite Courses | |
| Course Level | Undergraduate |
| Mode of delivery | Face to face |
| Course Coordinator | Dr. Öğr. Üyesi CEREN GÜNEY |
| Instructor(s) | Dr. Öğr. Üyesi CEREN GÜNEY (Güz) |
| Goals | The aim of this course is to teach the mechanisms that regulate the functioning of the central nervous system and the principles of chemotherapy and drugs used in the treatment of diseases that occur in cases of their disorder, and the issues to be considered during treatment with chemotherapeutic agents. |
| Course Content | 1. Learning the central nervous system and stimulants.2. Learning the drugs used in anesthesia. 3. Learning the drugs affecting the central nervous system (Sedative-hypnotics, anxiolytics, alcohol, antidepressants, antiepileptics, antiparkinsonian drugs) 4. Learning pain and pain medications. 5. Learning dermatologic drugs, antiparasitic and antifungal drugs 6. Learning chemotherapeutics (antiseptics, disinfectants, macrolide and lincosamide antibiotics, sulfonamides, penicillins, cephalosporins). 7. Learning antiparasitic, antimalarial, antiviral, antifungal drugs, immunomodulators and cancer chemotherapy. |
| # | Öğrenme Kazanımı |
| 1 | The ability to explain the neurochemical properties of the central nervous system |
| 2 | To be able to explain the pharmacokinetic and pharmacodynamic properties of drugs that affect the central nervous system |
| 3 | To know the pathophysiology of pain and inflammatory diseases |
| 4 | To learn pharmacokinetic and pharmacokinetic properties of drugs used in the treatment of pain and inflammatory diseases |
| 5 | Gaining knowledge about drug abuse and addiction |
| 6 | Learning the principles of chemotherapy |
| 7 | To obtain information about chemotherapeutic drugs and to know the issues to be considered during treatment with these drugs |
| Week | Topics/Applications | Method |
|---|---|---|
| 1. Week | Introduction to central nervous system, central nervous system stimulants | Preparation, After Class Study Interview Class Hours Research |
| 2. Week | Local anesthetics, general anesthetics, neuromuscular blocking drugs and central acting muscle relaxants | Interview Preparation, After Class Study Class Hours Research |
| 3. Week | Sedative-hypnotics, anxiolytics, alcohol | Preparation, After Class Study Class Hours Interview Research |
| 4. Week | Antidepressants, antiepileptics | Preparation, After Class Study Interview Class Hours Research |
| 5. Week | Neuroleptics, drugs used in the treatment of Alzheimer's and Parkinson's | Research Interview Class Hours Preparation, After Class Study |
| 6. Week | Introduction to pain, opioid analgesics | Research Class Hours Interview Preparation, After Class Study |
| 7. Week | Nonsteroidal anti-inflammatory drugs, treatment of migraine, gout and rheumatoid arthritis | Research Class Hours Preparation, After Class Study Interview |
| 8. Week | Principles of antimicrobial treatment, folate antagonists | Preparation, After Class Study Research Interview Class Hours |
| 9. Week | Cell wall synthesis inhibitors, protein synthesis inhibitors | Class Hours Preparation, After Class Study Research Interview |
| 10. Week | Protein synthesis inhibitors, quinolones and urinary systemantiseptics | Research Preparation, After Class Study Interview Class Hours |
| 11. Week | Antimycobacterial drugs, antifungal drugs, antiprotozoal drugs, antihelminthic drugs | Research Interview Class Hours Preparation, After Class Study |
| 12. Week | Antiviral drugs, cancer chemotherapy | Preparation, After Class Study Research Interview Class Hours |
| 13. Week | Cancer chemotherapy, immunomodulatory drugs | Preparation, After Class Study Research Class Hours Interview |
| 14. Week | Antiseptic-disinfectant drugs, dermatological drugs | Interview Research Preparation, After Class Study Class Hours |
| No | Program Requirements | Level of Contribution | |||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | Uses the knowledge and skills acquired by completing the pharmacy undergraduate programme in the application areas of the profession by taking initiative when necessary within the framework of ethical and deontological rules in line with the current laws, regulations and legislation. | ✔ | |||||
| 2 | Has sufficient knowledge and application skills about the physical and chemical structure, synthesis, microbiological and toxicological analysis, effects, structure-effect relationships, design and development, therapeutic dose determination, pharmacokinetic and pharmacodynamic properties of active and excipients, pharmaceutical preparations and medicinal products. | ✔ | |||||
| 3 | By adopting lifelong learning, pharmacy professional practices, science, technology, contemporary thinking and behaviour in the dimension of current information in the dimension of technological tools, databases and information resources. Develops, deepens, evaluates and uses this information for the benefit of society. | ✔ | |||||
| 4 | Takes an active role in the preparation, production, quality assurance and control, bioavailability and bioequivalence, licensing and patent studies, supply chain management and presentation of pharmaceutical, radiopharmaceutical, biotechnological, nanotechnological and cosmetic/cosmeceutical products containing natural or synthetic active ingredients. | ✔ | |||||
| 5 | Takes an active role in pharmacovigilance practices; uses the adverse effect reporting system; contributes to risk management and audit to ensure safe drug use. | ✔ | |||||
| 6 | Informs the patient, patient relatives and other health professionals to increase awareness of drug safety. | ✔ | |||||
| 7 | He/she has sufficient knowledge about the preparation of major medicines, the use and legislation of all original or generic preparations and medicinal products. | ||||||
| 8 | Has knowledge about the indications, route of administration and incompatibilities of the drugs prescribed to the patient, evaluation of clinical laboratory results in order to ensure and promote the most appropriate use of drugs within the framework of rational drug use. | ✔ | |||||
| 9 | Food supplements, nutraceuticals, cosmetics / cosmeceuticals, OTC, etc. has the competence to provide practical and useful information to the public about products. | ||||||
| 10 | Integrates and develops pharmacy professional knowledge with knowledge from different disciplines within the framework of pharmaceutical care and clinical pharmacy practice. | ✔ | |||||
| 11 | To be able to communicate effectively with the relevant legal authorities, physicians and health personnel, pharmaceutical industry and other stakeholders in order to improve the health level and quality of life of the society, and to be able to bring suggestions and solutions to the problems related to the field. | ✔ | |||||
| 12 | Has knowledge about the properties, usage areas, production, quality assurance, legislation and legal regulations of medical devices used for chronic diseases and other purposes. | ✔ | |||||
| 13 | They take part in the supply and presentation of pharmaceuticals and medical products and provide counselling services to patients on rational and safe use. | ✔ | |||||
| 14 | To be able to follow the information and developments in pharmacy practice areas by using at least one foreign language, to communicate with patients and colleagues, to express himself/herself verbally and in writing by participating in national and / or international activities and projects. | ✔ | |||||
| 15 | Has sufficient knowledge and application skills about various technological tools, information resources, software and artificial intelligence supported technologies required by pharmacy professional practice areas. | ✔ | |||||
| 16 | As a health professional providing primary health care services, provides healthy living counselling by managing patient records; promotes healthy living and fulfils professional responsibilities to protect public health. | ✔ | |||||
| 17 | He/she pays attention to the occupational safety of the employees under his/her responsibility and plans and manages their vocational training for their development within the framework of a project and monitors and evaluates the process. | ||||||
| 18 | Takes part in the development processes of the pharmacy profession and application areas related to pharmaceutical and health management; conducts research and development activities in accordance with scientific and ethical principles; analyses, evaluates, interprets and applies data. | ||||||
| 19 | Participates in quality management processes by documenting professional activities and practices effectively and safely in accordance with quality management and processes. | ||||||
| 20 | Be a role model for his/her colleagues and an example to the society with his/her attitude, behaviour and professional identity. | ✔ | |||||
| 21 | Has knowledge about anatomy, immunology, physiology, physiopathology and biochemistry of biological systems. Knows and relates the basic concepts of cognitive states and behaviours, mental and physical diseases, symptoms and treatments that affect human health. | ✔ | |||||
| Program Requirements | DK1 | DK2 | DK3 | DK4 | DK5 | DK6 | DK7 |
|---|---|---|---|---|---|---|---|
| PY1 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| PY2 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| PY3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| PY4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| PY5 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| PY6 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| PY7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PY8 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| PY9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PY10 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| PY11 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| PY12 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| PY13 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| PY14 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| PY15 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| PY16 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| PY17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PY18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PY19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PY20 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| PY21 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Ders Kitabı veya Notu | Ders Kitabı veya Ders Notu bulunmamaktadır. |
|---|---|
| Diğer Kaynaklar |
|
| Güz Dönemi | |||
| Responsible Personnel | Grup | Evaluation Method | Percentage |
|---|---|---|---|
| Dr. Öğr. Üyesi CEREN GÜNEY | Vize | 40.00 | |
| Dr. Öğr. Üyesi CEREN GÜNEY | Final | 60.00 | |
| Toplam | 100.00 | ||
| ECTS credits and course workload | Quantity | Duration (Hour) | Total Workload (Hour) | |
|---|---|---|---|---|
|
Ders İçi |
Class Hours | 14 | 3 | 42 |
|
Ders Dışı |
Preparation, After Class Study | 14 | 1.5 | 21 |
| Research | 7 | 1.5 | 10.5 | |
| Other Activities | 2 | 0.5 | 1 | |
|
Sınavlar |
Midterm 1 | 1 | 1 | 1 |
| Final | 1 | 1 | 1 | |
| Total Workload | 76.5 | |||
| *AKTS = (Total Workload) / 25,5 | ECTS Credit of the Course | 3.0 | ||
